About Soteri Skin
Soteri Skin is a science-driven skincare company founded by Harvard Biomedical Chemistry PhD Dr. Rafal Pielak and incubated at Harvard Innovation Labs. Developed in response to real-world eczema challenges, the brand focuses on delivering clinically validated, non-steroidal solutions for sensitive and compromised skin.
At the core of Soteri Skin’s innovation is its patented pH/LOCK® technology, designed to restore and maintain the skin’s natural acid mantle at an optimal pH of 4.7. By supporting the skin’s barrier function and microbiome, Soteri Skin aims to provide long-term relief from eczema symptoms without relying on steroids.
What is the Soteri Skin Eczema Relief Kit?
The Soteri Skin Eczema Relief Kit is a two-step, non-steroidal skincare regimen formulated to address the root causes of eczema by correcting and stabilizing the skin’s pH.
Recommended by leading dermatologists, including Dr. Peter Lio, this system is designed to deliver both immediate comfort and long-term skin health benefits.
Key benefits include:
Steroid-free formulation suitable for ongoing use
Helps correct and maintain optimal skin pH levels
Supports a balanced skin microbiome
Locks in hydration both immediately and over time
Lightweight, fast-absorbing, non-greasy texture
Powered by pH/LOCK® technology, the regimen works to calm irritation, strengthen the skin barrier, and help prevent future flare-ups.
How Was the Skin Eczema Relief Kit Tested?
A virtual consumer perception study was conducted to evaluate the effectiveness of the Soteri Skin pH/LOCK® two-step regimen.
Participants:
40 total participants (36 completed the study)
Age range: 3–9 (with parental consent) and 18–65
All participants reported symptoms such as redness, itching, dryness, irritation, and discomfort
Study Design:
Duration: 12 weeks
Participants applied:
Step 1 (pH/LOCK® Lite) through Week 2
Step 2 (pH/LOCK®) from Week 3 through Week 6
Products were applied twice daily to affected areas
Assessments conducted at Baseline, Day 1, Week 2, Week 6, and Week 12
Participants completed questionnaires and submitted photos at key intervals
Data Collection:
Responses measured using a 5-point Likert scale
“Agree” and “Strongly Agree” responses combined for analysis
Severity and satisfaction also measured using 1–10 rating scales
Why Clinical Research Matters
Eczema is a complex skin condition influenced by barrier dysfunction, microbiome imbalance, and inflammation. Products supported by clinical or consumer perception studies provide valuable insight into real-world performance and user experience.
By evaluating outcomes such as symptom relief, hydration, and quality of life over time, clinical research helps consumers make informed decisions and builds trust in product efficacy, especially for sensitive skin conditions where safety and consistency are critical.
Study Results
Participants reported progressive improvements across multiple eczema-related symptoms throughout the study period.
By Week 12:
97% of participants agreed that, since using this product, their eczema symptoms have reduced.
94% of participants agreed that since using this product, their skin feels less irritated.
97% of participants agreed that, since using this product, they have felt less skin discomfort.
88% of participants agreed that since using this product, they have experienced fewer pain sensations in their skin.
86% of participants agreed that since using this product, they have experienced less night itching.
100% of participants agreed that the product was more effective in supporting their skin than other topicals/creams/ointments they have used in the past.
User Experience:
100% found the product easy to use and would recommend it
94.44% were satisfied with results and would continue use